Published in Heart Disease Weekly, January 19th, 2003
Under terms of the agreements, Edwards obtains an exclusive worldwide license to submucosa tissue technology developed by Cook Biotech, as well as access to all related intellectual property rights for development of specific cardiovascular implants. Financial details of the agreements were not disclosed.
"Edwards is the world's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.